Global Candidiasis Therapeutics Market Analysis 2013-2018 and Forecast 2019-2024

Table of Contents

1 Industry Overview

• 1.1 Candidiasis Therapeutics Industry
  • 1.1.1 Overview
  • 1.1.2 Development of Candidiasis Therapeutics
• 1.2 Market Segment
  • 1.2.1 Upstream
  • 1.2.2 Downstream
• 1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

• 2.1 Policy
• 2.2 Economics
• 2.3 Sociology
• 2.4 Technology

3 Candidiasis Therapeutics Market by Type

• 3.1 By Type
  • 3.1.1 Doxorubicin
  • 3.1.2 Cisplatin
  • 3.1.3 7Carboplatin
  • 3.1.4 Etoposide
  • 3.1.5 Ifosfamide
  • 3.1.6 Cyclophosphamide
  • 3.1.7 Methotrexate
  • 3.1.8 Vincristine
• 3.2 Market Size
• 3.3 Market Forecast

4 Major Companies List

4.Candidiasis Therapeutics Novartis AG (Company Profile, Sales Data etc.)

• 4.2 Amgen (Company Profile, Sales Data etc.)
• 4.3 F. Hoffmann-La Roche Ltd. (Company Profile, Sales Data etc.)
• 4.4 Bayer-Algeta (Company Profile, Sales Data etc.)
• 4.5 Merrion Pharmaceuticals Plc. (Company Profile, Sales Data etc.)
• 4.6 Ablynx (Company Profile, Sales Data etc.)
• 4.7 Genta Incorporated (Company Profile, Sales Data etc.)
• 4.8 Galapagos NV (Company Profile, Sales Data etc.)
• 4.9 Catena Pharmaceuticals Inc. (Company Profile, Sales Data etc.)
• 4.10 Digna Biotech S.L. (Company Profile, Sales Data etc.)
• 4.11 Medivir AB (Company Profile, Sales Data etc.)
• 4.12 Amura Holdings (Company Profile, Sales Data etc.)

5 Market Competition

• 5.1 Company Competition
• 5.2 Regional Market by Company

6 Demand by End Market

• 6.1 Demand Situation
  • 6.1.1 Demand in Multispecialty Hospitals
  • 6.1.2 Demand in Cancer Research Institutes
  • 6.1.3 Demand in Others
• 6.2 Regional Demand Comparison
• 6.3 Demand Forecast

7 Region Operation

• 7.1 Regional Production
• 7.2 Regional Market
• 7.3 by Region
  • 7.3.1 North America
    • 7.3.1.1 Overview
    • 7.3.1.2 by Country (U.S., Canada, Mexico)
  • 7.3.2 Europe
    • 7.3.2.1 Overview
    • 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
  • 7.3.3 Asia-Pacific
    • 7.3.3.1 Overview
    • 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
  • 7.3.4 South America
    • 7.3.4.1 Overview
    • 7.3.4.2 by Country (Brazil, Argentina etc.)
  • 7.3.5 Middle East & Africa
    • 7.3.5.1 Overview
    • 7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
• 7.4 Regional Import & Export
• 7.5 Regional Forecast

8 Marketing & Price

• 8.1 Price and Margin
  • 8.1.1 Price Trends
  • 8.1.2 Factors of Price Change
  • 8.1.3 Manufacturers Gross Margin Analysis
• 8.2 Marketing Channel

9 Research Conclusion

List of Tables

Table Upstream Segment of Candidiasis Therapeutics

Table Application Segment of Candidiasis Therapeutics

Table Global Candidiasis Therapeutics Market 2013-2024, by Application, in USD Million

Table Major Company List of Doxorubicin

Table Major Company List of Cisplatin

Table Major Company List of 7Carboplatin

Table Major Company List of Etoposide

Table Major Company List of Ifosfamide

Table Major Company List of Cyclophosphamide

Table Major Company List of Methotrexate

Table Major Company List of Vincristine

Table Global Candidiasis Therapeutics Market 2013-2018, by Type, in USD Million

Table Global Candidiasis Therapeutics Market 2013-2018, by Type, in Volume

Table Global Candidiasis Therapeutics Market Forecast 2019-2024, by Type, in USD Million

Table Global Candidiasis Therapeutics Market Forecast 2019-2024, by Type, in Volume

Table Novartis AG Overview List

Table Candidiasis Therapeutics Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Amgen Overview List

Table Candidiasis Therapeutics Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table F. Hoffmann-La Roche Ltd. Overview List

Table Candidiasis Therapeutics Business Operation of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Bayer-Algeta Overview List

Table Candidiasis Therapeutics Business Operation of Bayer-Algeta (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Merrion Pharmaceuticals Plc. Overview List

Table Candidiasis Therapeutics Business Operation of Merrion Pharmaceuticals Plc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Ablynx Overview List

Table Candidiasis Therapeutics Business Operation of Ablynx (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Genta Incorporated Overview List

Table Candidiasis Therapeutics Business Operation of Genta Incorporated (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Galapagos NV Overview List

Table Candidiasis Therapeutics Business Operation of Galapagos NV (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Catena Pharmaceuticals Inc. Overview List

Table Candidiasis Therapeutics Business Operation of Catena Pharmaceuticals Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Digna Biotech S.L. Overview List

Table Candidiasis Therapeutics Business Operation of Digna Biotech S.L. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Medivir AB Overview List

Table Candidiasis Therapeutics Business Operation of Medivir AB (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Amura Holdings Overview List

Table Candidiasis Therapeutics Business Operation of Amura Holdings (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Candidiasis Therapeutics Sales Revenue 2013-2018, by Company, in USD Million

Table Global Candidiasis Therapeutics Sales Revenue Share, by Company, in USD Million

Table Global Candidiasis Therapeutics Sales Volume 2013-2018, by Company, in Volume

Table Global Candidiasis Therapeutics Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Candidiasis Therapeutics Demand Forecast 2019-2024, by Application, in USD Million

Table Candidiasis Therapeutics Demand Forecast 2019-2024, by Application, in Volume

Table Candidiasis Therapeutics Production 2013-2018, by Region, in USD Million

Table Candidiasis Therapeutics Production 2013-2018, by Region, in Volume

Table Global Candidiasis Therapeutics Market 2013-2018, by Region, in USD Million

Table Global Candidiasis Therapeutics Market Share 2013-2018, by Region, in USD Million

Table Global Candidiasis Therapeutics Market 2013-2018, by Region, in Volume

Table Global Candidiasis Therapeutics Market Share 2013-2018, by Region, in Volume

Table North America Candidiasis Therapeutics Market Size 2013-2018, by Country, in USD Million

Table North America Candidiasis Therapeutics Market Size 2013-2018, by Country, in Volume

Table Europe Candidiasis Therapeutics Market Size 2013-2018, by Country, in USD Million

Table Europe Candidiasis Therapeutics Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Candidiasis Therapeutics Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Candidiasis Therapeutics Market Size 2013-2018, by Country, in Volume

Table South America Candidiasis Therapeutics Market Size 2013-2018, by Country, in USD Million

Table South America Candidiasis Therapeutics Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Candidiasis Therapeutics Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Candidiasis Therapeutics Market Size 2013-2018, by Country, in Volume

Table Candidiasis Therapeutics Market Forecast 2019-2024, by Region, in USD Million

Table Candidiasis Therapeutics Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

List of Figures

Figure Global Candidiasis Therapeutics Market Growth 2013-2018, by Type, in USD Million

Figure Global Candidiasis Therapeutics Market Growth 2013-2018, by Type, in Volume

Figure North America Candidiasis Therapeutics Market Concentration, in 2018

Figure Europe Candidiasis Therapeutics Market Market Concentration, in 2018

Figure Asia-Pacific Candidiasis Therapeutics MMarket Concentration, in 2018

Figure South America Candidiasis Therapeutics Market Concentration, in 2018

Figure Middle East & Africa Candidiasis Therapeutics Market Concentration, in 2018

Figure Candidiasis Therapeutics Demand in Multispecialty Hospitals, 2013-2018, in USD Million

Figure Candidiasis Therapeutics Demand in Multispecialty Hospitals, 2013-2018, in Volume

Figure Candidiasis Therapeutics Demand in Cancer Research Institutes, 2013-2018, in USD Million

Figure Candidiasis Therapeutics Demand in Cancer Research Institutes, 2013-2018, in Volume

Figure Candidiasis Therapeutics Demand in Others, 2013-2018, in USD Million

Figure Candidiasis Therapeutics Demand in Others, 2013-2018, in Volume

Figure North America Candidiasis Therapeutics Market Size and Growth 2013-2018, in USD Million

Figure North America Candidiasis Therapeutics Market Size and Growth 2013-2018, in Volume

Figure Europe Candidiasis Therapeutics Market Size and Growth 2013-2018, in USD Million

Figure Europe Candidiasis Therapeutics Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Candidiasis Therapeutics Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Candidiasis Therapeutics Market Size and Growth 2013-2018, in Volume

Figure South America Candidiasis Therapeutics Market Size and Growth 2013-2018, in USD Million

Figure South America Candidiasis Therapeutics Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Candidiasis Therapeutics Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Candidiasis Therapeutics Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview